Pages

Thursday, 30 October 2014

Two agricultural names...Mosaic and Bunge

It was not that long ago that I last wrote about Mosaic noting about a month ago (link here) after the company pulled back some profit guidance that:

'my conclusion is to cover my short at c. US$44 (and taking some pleasant profits) and await a run / new newsflow towards US$40 to consider establishing a long...'

Well since then the share did give me an opportunity to cover my short but did not quite provide a level to establish a long:


So what to think following the posting of the full set of quarterly numbers?  Well I liked the way the company opened up its presentation document:

The issue - as indicated at the time of the profits downgrade - was sourced in the potash division.  Note the poor operating rate level, patchy pricing and hence poor operating earnings levels.  Phosphates may make the company much more money today but potash is the real flex factor.  

Now the guidance is for some Q4 improvements especially in the operating rate and this may have helped boost the view that it was also the time to use the balance sheet:


Mosaic is an interesting company but given my already high agriculture-focused shareholdings (Deere, Syngenta, Agco etc) I am going to wait for that c. US$40 level.  Certainly though risk-reward is improving and I am glad I am no longer short (even though it was nicely profitable as a trade). 

The agribusiness Bunge is not currently a holding although I have been involved in the past.  The whole agribusiness space is quite fascinating given the growth of global agricultural trade...and the five year share price chart looks quite different from many other sector stocks: 


Divisionally the agribusiness drove the numbers albeit the year-on-year progress continued to be not as good as in 2013...


...and the forward comments were still good.

Elsewhere the food/ingredients division should continue to have a record year whilst the problematic sugar/bioenergy division is anticipated to be 'breakeven'.  

So that all sounds fine.  But for x17 current EV/ebit and a relatively modest c. 1.5% dividend yield?  I like the theme but prefer to wait for a cuter entry level at least in the US$70-75 range.  The 10 December investor day should be quite interesting however.  

No comments:

Post a Comment